Search - tctmd.com

Displaying 721 - 740 of 3208

Sort: Relevancy | Date

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Industry News

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

October 13, 2015

News Conference News TCT 2015

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

October 13, 2015

News Daily News

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

L.A. McKeown

October 13, 2015

Presentation TCT 2015

Case 3: Hot ACS and a History of Possible Aspirin Anaphylaxis

Presenter: Paul A. Gurbel, Daniel I. Simon, Thomas D. Stuckey

October 12, 2015

Presentation TCT 2015

CTO PCI in Patients With ACS and Multivessel Disease

Presenter: R. Michael Wyman, Renato Valenti

October 12, 2015

$Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Unfractionated Heparin!$

Presentation TCT 2015

Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Unfractionated Heparin!

Presenter: John A. Bittl, Robert A. Harrington, Michael S. Lee

October 12, 2015

Presentation TCT 2015

Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Bivalirudin!

Presenter: John A. Bittl, Robert A. Harrington, George D. Dangas

October 12, 2015

Presentation TCT 2015

Is Prolonged Antithrombin Use After Primary PCI in STEMI Beneficial?

Presenter: John A. Bittl, Robert A. Harrington, Mahesh Madhavan

October 12, 2015

Presentation TCT 2015

Procedural Anticoagulants in Sweden: Results From the SCAAR Registry and Rationale for VALIDATE-SWEDEHEART

Presenter: John A. Bittl, Robert A. Harrington, David Erlinge

October 12, 2015

Presentation TCT 2015

Cangrelor + Bivalirudin: The Perfect Marriage or a Forced Union?

Presenter: John A. Bittl, Robert A. Harrington, Harvey D. White

October 12, 2015

Presentation TCT 2015

What, if Any, Is the Role for LMWH and GP IIb/IIIa Inhibitors in ACS or During PCI?

Presenter: John A. Bittl, Robert A. Harrington, Jorge F. Saucedo

October 12, 2015

Presentation TCT 2015

Bivalirudin Pearls: Necessity With Radial Access, Infusion Dose and Duration, Use in CKD, and More

Presenter: John A. Bittl, Robert A. Harrington, Philippe Gabriel Steg

October 12, 2015

Presentation TCT 2015

Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results

Presenter: John A. Bittl, Robert A. Harrington, Marco Valgimigli

October 12, 2015

Presentation TCT 2015

CTO Intervention in ACS With Complications: Case Reviews

Presenter: Matjaz Bunc, Christos Christou, Sasko Kedev, Milan A. Nedeljkovic, Georgios Sianos, Sinisa Stojkovic

October 12, 2015

Presentation TCT 2015

FFR: Left Main, Serial Lesions, and ACS Cases

Presenter: Habib Samady

October 12, 2015

Presentation TCT 2015

ACS Networks in Switzerland

Presenter: Aleksander Ernst, Guy J. Friedrich, Thomas Pilgrim

October 12, 2015

Presentation TCT 2015

ACS Networks in Slovakia

Presenter: Aleksander Ernst, Guy J. Friedrich, Martin Studencan

October 12, 2015

Presentation TCT 2015

ACS Networks in Germany

Presenter: Aleksander Ernst, Guy J. Friedrich, Jochen Wöhrle

October 12, 2015

Presentation TCT 2015

ACS Networks in the Czech Republic

Presenter: Aleksander Ernst, Guy J. Friedrich, Petr Kala

October 12, 2015

Advertisement

Discussion Highlights Merits, Limitations of Small Trials

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

CENTURY II: Bioresorbable-Polymer DES Safe, Effective at 2 Years

Abordaje Híbrido con Pruebas de Imágenes Ofrece Elevada Capacidad de Discriminación de las Placas Coronarias Vulnerables

Case 3: Hot ACS and a History of Possible Aspirin Anaphylaxis

CTO PCI in Patients With ACS and Multivessel Disease

Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Unfractionated Heparin!

Debate: Bivalirudin vs Heparin During PCI in Stable CAD? Bivalirudin!

Is Prolonged Antithrombin Use After Primary PCI in STEMI Beneficial?

Procedural Anticoagulants in Sweden: Results From the SCAAR Registry and Rationale for VALIDATE-SWEDEHEART

Cangrelor + Bivalirudin: The Perfect Marriage or a Forced Union?

What, if Any, Is the Role for LMWH and GP IIb/IIIa Inhibitors in ACS or During PCI?

Bivalirudin Pearls: Necessity With Radial Access, Infusion Dose and Duration, Use in CKD, and More

Bivalirudin vs Heparin in ACS: The New Data MATRIX Antithrombin Results

CTO Intervention in ACS With Complications: Case Reviews

FFR: Left Main, Serial Lesions, and ACS Cases

ACS Networks in Switzerland

ACS Networks in Slovakia

ACS Networks in Germany

ACS Networks in the Czech Republic

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content